Approval · Notice of Compliance 2653 · 2001
TOMYCINE: Notice of Compliance 2653
Issued February 16, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2653
- Date
- February 16, 2001
- Company
- Novartis Ophthalmics Novartis Pharmaceuticals (Canada) IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Topical antibiotic
- Canadian reference product
- TOBREX
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TOMYCINE | 02238708 | — |
Medicinal ingredients
- TOBRAMYCIN 3 MG per ML